EDITOR’S PICK
When protein stability drives tumor progression
 
More details
Hide details
1
Department of Human Immunology, Faculty of Medicine, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland
 
2
Institute of Biology, University of Szczecin, Szczecin, Poland
 
3
Center for Experimental Immunology and Immunobiology in Infectious Diseases and Cancer, University of Szczecin, Szczecin, Poland
 
4
Centre of Regenerative Medicine, Medical University of Bialystok, Bialystok, Poland
 
5
Tissue and Cell Bank, Medical University of Bialystok Clinical Hospital, Bialystok, Poland
 
 
Publication date: 2026-05-16
 
 
Cent Eur J Immunol 2026;51(1):1-2
 
REFERENCES (8)
1.
Shurin MR, Umansky V (2022): Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapy. J Clin Invest 132: e159473.
 
2.
Galon J, Bruni D (2020): Tumor immunology and tumor evolution: Intertwined histories. Immunity 52: 55-81.
 
3.
Qin L, Yang N, Yang F, et al. (2026): RAB40C regulates SNX9 stability via the ubiquitin-proteasome system and modulates the Hippo signaling pathway of prostate adenocarcinoma. Cent Eur J Immunol 51: 31-50.
 
4.
Bin Y, Guikang L, Jin H, et al. (2023): Notch signaling pathway-based classification of bladder cancer in relation to tumor immune infiltration. Cent Eur J Immunol 48: 274-289.
 
5.
Ge J, Feng R, Zhu F, et al. (2024): STK11 mutation affects tumor proliferation by impacting CD4. Cent Eur J Immunol 49: 320-330.
 
6.
Zhou L, Ma D, Li X, et al. (2025): Macrophage M2 polarization induced by ANKRD22 in lung adenocarcinoma facilitates tumor angiogenesis. Cent Eur J Immunol 50: 38-51.
 
7.
Baroja I, Kyriakidis NC, Halder G, Moya IM (2024): Expected and unexpected effects after systemic inhibition of Hippo transcriptional output in cancer. Nat Commun 15: 2700.
 
8.
Kim HS, Nam JS (2025): The multifaceted role of YAP in the tumor microenvironment and its therapeutic implications in cancer. Exp Mol Med 57: 2201-2213.
 
eISSN:1644-4124
ISSN:1426-3912
Journals System - logo
Scroll to top